Futura Medical (LON:FUM) Stock Rating Reaffirmed by Liberum Capital

Futura Medical (LON:FUM)‘s stock had its “under review” rating reiterated by investment analysts at Liberum Capital in a note issued to investors on Thursday, ThisIsMoney.Co.Uk reports.

LON FUM opened at GBX 12.13 ($0.16) on Thursday. The stock has a market cap of $29.78 million and a PE ratio of -2.53. Futura Medical has a twelve month low of GBX 7.60 ($0.10) and a twelve month high of GBX 47.90 ($0.63). The stock has a fifty day simple moving average of GBX 12.01 and a 200-day simple moving average of GBX 27.45.

About Futura Medical

Futura Medical plc develops pharmaceutical drugs and medical devices for the consumer healthcare markets focusing on sexual healthcare and pain relief management. The company offers CSD500, a condom that incorporates an erectogenic gel to help men maintain a firmer erection during intercourse whilst wearing a condom.

Featured Story: How Investors Can Profit from Options Trading

Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.